TrialHead & neck2016

Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma.

Min Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.